Purchase Order 75N95020P00679
- Not listed
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for IPSC engineering services. The firm-fixed-price contract, valued at $1,939,814.20, does not have a set-aside designation. Through this contract, Synthego will provide the NIH with various gene editing products and services, including custom cell clones,...
- This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
- This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences to Synthego Corporation, a self-certified small disadvantaged business, for high-throughput screening to identify modulators of the expression of human HIF1 and HIF2. The firm fixed price purchase order, valued at $22,650.00, will support genetic research at Synthego's facilities in Redwood City, California through...
- This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
- This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
- This is a $12,775 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for Synthego to provide knock-in cell line generation services to support cell biology experiments for Dr. Martina. While this contract is not set aside, Synthego has previously been awarded over 30 prime federal...
- The National Institute on Drug Abuse awarded a $223,632 firm fixed-price purchase order to Synthego Corporation on September 23, 2020, for the development of induced pluripotent stem (IPS) cell lines expressing HiBiT at specified health-related genes. The contract, which involved no small business set-aside, was performed in Redwood City, California, with an ultimate completion date of March 31, 2021. This award represented the de-obligation of unexpended and expiring fiscal year 2020 funding in...
- This is a federal contract award by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is a $46,600 firm fixed-price purchase order with a completion date of November 15, 2020. The contract does not have a set-aside designation. Synthego specializes in providing genome engineering solutions, including...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a firm-fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, to create genetically modified cell lines. The $36,300.03 contract requires Synthego to deliver two homozygous and two heterozygous POLR3B cell line clones, as well as two homozygous and two heterozygous POLR3E cell line clones, all derived from...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for the development of induced pluripotent stem (iPS) report cell lines expressing HiBiT at specified target genes. The $235,150.00 contract has a 20-24 week period of performance and does not have a set-aside designation. The work will be performed at Synthego's facilities in Redwood City, California. Synthego has previously delivered gene editing products, cell line engineering, and CRISPR libraries to various government agencies under over 30 federal contracts, supporting research across translational science, infectious diseases, and environmental health.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Development of iPS report cell lines expressing HiBiT at specified target genes | 75N95020Q00326 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 9/10/20, 9:35 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 1/11/23 | |
| Not listed | Not listed | $235.2k | 9/18/20 |